SynAct Pharma
Invitation to Synact’s Capital Markets Day
SynAct Pharma AB (“SynAct”) (Nasdaq Stockholm: SYNACT), a clinical-stage biotechnology company focused on resolving inflammation through selective activation of the melanocortin system, invites investors, analysts and media to a Capital Markets Day on September 23 in Stockholm.
The agenda and more detailed information will be announced closer to the event.
Location: GT30, Grev Turegatan 30, 114 38 Stockholm, Sweden
Date: Monday, September 23, 2024
Time: 10.00-13:00. The venue opens at 09:30.
Registration for the Capital Markets Day is made by emailing investor.relations@synactpharma.com
The last day to register is September 19, 2024.
For further information, please contact:
Jeppe Øvlesen
CEO, SynAct Pharma AB
Phone: + 45 2844 7567
E-mail: investor.relations@synactpharma.com
About SynAct Pharma AB
SynAct Pharma AB (Nasdaq Stockholm: SYNACT) is a clinical stage biotechnology company focused on the resolution of inflammation through the selective activation of the melanocortin system. The company has a broad portfolio of oral and injectable selective melanocortin agonists aimed at inducing anti-inflammatory and inflammation resolution activity to help patients achieve immune balance and overcome their inflammation. For more information: www.synactpharma.com.
| Datum | 2024-08-20, kl 08:00 |
| Källa | MFN |
Alla Aktier tipsar: Har du redan ett konto på Avanza? Varför inte skapa ett på Nordnet också och jämföra funktioner, courtage mm. Det tar inte lång tid, du fixar det direkt här med BankID